Our environment
Partner platforms
Screening
- Strasbourg Platform for Integrative Chemistry and Biology (PCBIS)
- Download the platform sheet
- Screening Platform for Bio-Active Molecules (CMBA), CEA Grenoble
- Download the platform sheet
- High-throughput screening and combinatorial chemistry platform, CEA Saclay
- Ariadne platform
- Download the platform sheet
- Plateforme Centre de Découverte et de Développement du Médicament (C3D) (Drug Discovery and Development Center)
- Download the platform sheet
- BioPhenics cell screening platform - Platform Institut Curie
- Screening Platform at the Institut de la Vision
- Download the platform sheet
- ChemBioFrance infrastructure
- Prestwick Chemical- Greenpharma SAS
- Download the platform sheet
- PhenoFish platform
-Download the platform sheet
- I-Stem platform
- Download the platform sheet
- Therassay platform
- Download the platform sheet
- Paris Saclay Screening Platform (C@PS)
- Download the platform sheet
- CBC Biological Screening Platform and Chemical Libraries
- Download the platform sheet
- Marseille-Luminy screening platform
- Platform ARPEGE (Pharmacology Screening Interactome)
- ImPACcell platform
- Download the platform sheet
- Toulouse integrated screening platform (PICT)
- IGBMC high-throughput cell screening platform
- Download the platform sheet
- Screenia platform - Medetia SAS
- Download the platform sheet
- Biogenouest
High-speed sequencing
Creation of experimental models
- Marseille Stem Cell Platform (MaSC)
Marseille - Download the platform sheet
- Phenomin Infrastructure
: Institut Clinique de la Souris, Strasbourg
, CIPHE
(Center for ImmunoPHEnogenomics), Marseille
- Download the platform sheet
- Platform Rat Transgenesis and Immunophenomics TRIP
Nantes - Download the platform sheet
- Platform SEGiCel
, Lyon - Download the platform sheet
- Platform iPSC Nantes
- Download the platform sheet
- Zebrafish platform Tefor
Paris Saclay - Download the platform sheet
For projects based on specific technological approaches concerning screening, high-throughput sequencing or the creation of experimental models, partnerships can be extended to other platforms.
Contact us: aap-bio(@)fondation-maladiesrares.com